European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia?

Englert, H. S., Müller‐Nordhorn, J., Seewald, S., Sonntag, F., Völler, H., Meyer-Sabellek, W. A., Wegscheider, K., Windler, E., Katus, H. A., & Willich, S. (2010) · Journal of Public Health · doi:10.1093/pubmed/fdq013 · Cited by 36

The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk

Schuster, H. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.2.177 · Cited by 40

Social disparities in diabetes care: a general population study in Denmark

Heltberg, A., Andersen, J. S., Kragstrup, J., et al. (2017) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2017.1288702 · Cited by 37

Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage

Poluzzi, E., Strahinja, P., Vaccheri, A., Vargiu, A., Silvani, M. C., Motola, D., Marchesini, G., Ponti, F. D., & Montanaro, N. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02801.x · Cited by 37

Recommendations for sample selection, collection and preparation for NMR-based metabolomics studies of blood

Emwas, A.-H. M., Zacharias, H. U., Alborghetti, M. R., Gowda, G. A. N., Raftery, D., McKay, R. T., Chang, C., Saccenti, E., Gronwald, W., Schuchardt, S., et al. (2025) · Metabolomics · doi:10.1007/s11306-025-02259-7 · Cited by 42

Steady and unsteady non-Newtonian inelastic flows in a planar T-junction

Matos, H., & Oliveira, P. J. (2012) · International Journal of Heat and Fluid Flow · doi:10.1016/j.ijheatfluidflow.2012.11.005 · Cited by 36

The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population

Falk, E., Sillesen, H. H., Muntendam, P., & Fuster, V. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0193-0 · Cited by 37

Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy

Orzella, L., Chini, F., Rossi, P. G., et al. (2010) · Health Policy · doi:10.1016/j.healthpol.2009.12.005 · Cited by 36

Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1

Májek, P., Reicheltová, Z., Suttnar, J., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-84 · Cited by 36

Prevalence and Characteristics of Lipid Abnormalities in Patients Treated With Statins in Primary and Secondary Prevention in Spain. DYSIS-Spain Study

González‐Juanatey, J. R., Millán, J., Alegría, E., Guijarro, C., Lozano, J. V., & Vitale, G. C. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2010.10.030 · Cited by 35

Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Pavasini, R., Cirillo, C., Campo, G. C., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002692 · Cited by 36

Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies

Irawati, S., Wasir, R., Schmidt, A. F., Islam, A., Feenstra, T., Buskens, E., Wilffert, B., & Hak, E. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1491149 · Cited by 35

General practitioners’ perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies

Ju, I. E., Banks, E., Calabria, B., Ju, A., Agostino, J., Korda, R., Usherwood, T. P., Manera, K., Hanson, C. S., Craig, J. C., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021137 · Cited by 36

Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low–intermediate risk

Lau, K. K., Chan, Y., Yiu, K., et al. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.064089 · Cited by 36

Family burden of cardiovascular mortality: risk implications for offspring in a national register linkage study based upon the Malmö Preventive Project

Nilsson, P. M., Nilsson, J. ‐., & Berglund, G. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01287.x · Cited by 36

The polypill concept

Wald, N., & Wald, D. S. (2009) · Postgraduate Medical Journal · doi:10.1136/hrt.2009.186429 · Cited by 36

Cardiovascular risk: prevention and treatment of the metabolic syndrome.

Tuomilehto, J. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.018 · Cited by 38

Ineffectiveness of lipid‐lowering therapy in primary care

Ganse, E. H. V., Souchet, T., Laforest, L., Moulin, P., Bertrand, M. E., Jeunne, P. L., Travier, N., Yin, D., Alemao, E., & de Pouvourville, G. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02266.x · Cited by 36

Consequences of using different methods to assess cardiovascular risk in primary care

Fornasini, M., Brotons, C., Sellarès, J., et al. (2005) · Family Practice · doi:10.1093/fampra/cmi092 · Cited by 36

Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)

Antoni, M. L., Hoogslag, G. E., Boden, H., Liem, S., Boersma, E. H., Fox, K. M., Schalij, M. J., Bax, J. J., & Delgado, V. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.029 · Cited by 32

Clinical Presentation of Hypertensive Crises in Emergency Medical Services

Salkić, S., Batić-Mujanović, O., Ljuca, F., et al. (2014) · Materia Socio Medica · doi:10.5455/msm.2014.26.12-16 · Cited by 35

Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer

Puhan, M. A., Yu, T., Stegeman, I., Varadhan, R., Singh, S., & Boyd, C. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0493-2 · Cited by 35

Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program

Pollin, T. I., Isakova, T., Jablonski, K. A., de Bakker, P. I. W., Taylor, A., McAteer, J. B., Pan, Q., Horton, E. S., Delahanty, L. M., Altshuler, D., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002895 · Cited by 35

Do practitioners and friends support patients with coronary heart disease in lifestyle change? a qualitative study

Cole, J. A., Smith, S. M., Hart, N. D., & Cupples, M. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-126 · Cited by 35

Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose–Response Meta-analysis of Prospective Cohort Studies

Zhao, L., Hu, M. X., Yang, L., Xu, H., Song, W., Qian, Y., & Zhao, M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000739 · Cited by 35

Cardiovascular risk factors and mortality in patients with coronary heart disease

Prugger, C., Wellmann, J., Heidrich, J., Brand‐Herrmann, S., & Keil, U. (2008) · European Journal of Epidemiology · doi:10.1007/s10654-008-9291-x · Cited by 35

Control de factores de riesgo y tratamiento de la aterotrombosis. Registro REACH España

Suárez, C., Cairols, M. A., Castillo, J., et al. (2007) · Medicina Clínica · doi:10.1016/s0025-7753(07)72882-8 · Cited by 35

Historical milestones in measurement of HDL-cholesterol: Impact on clinical and laboratory practice

Langlois, M. R., & Blaton, V. H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.01.031 · Cited by 34

Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain

Rallo, B. L., Blanco-Gonzalez, M., Casas-Ciria, I., Marín-Andrade, J. A., Mendez-Segovia, J. C., Moratalla, G., Quintero-Dominguez, R., Ramirez-Raya, M., Guerrero-Pinedo, M. J., & Aguilar‐Diosdado, M. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.028 · Cited by 33

Effect of Lifestyle Changes on Atherogenic Lipids and Endothelial Cell Adhesion Molecules in Young Adults With Familial Premature Coronary Heart Disease

Tonstad, S., Sundfør, T. M., & Seljeflot, I. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.047 · Cited by 35

Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia

Stein, E. A., Amerena, J. V., Ballantyne, C. M., Brice, E., Farnier, M., Guthrie, R. M., Harats, D., Ma, P. T. S., Maulf, F. L., Melezínková, H., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.029 · Cited by 35

Inclusion of Stroke as an Outcome and Risk Equivalent in Risk Scores for Primary and Secondary Prevention of Vascular Disease

Dhamoon, M. S., & Elkind, M. S. V. (2010) · Circulation · doi:10.1161/circulationaha.109.921072 · Cited by 35

New aspects of liver abnormalities as part of the systemic mast cell activation syndrome

Alfter, K., von Kügelgen, I., Haenisch, B., Frieling, T., Hülsdonk, A., Haars, U., Rolfs, A., Noe, G., Kolck, U. W., Homann, J., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01839.x · Cited by 35

Statins: can the new generation make an impression?

Rosenson, R. S. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.9.2.269 · Cited by 35

Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population

Ascaso, J. F., Millán, J., Mateo‐Gállego, R., Ruiz, A., Tembra, M. S., Borrallo, R. M., Zambón, D., González‐Santos, P., Peres-de-Juan, M., & Ros, E. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.12.011 · Cited by 34

CHA2DS2-VASc-HSF score – New predictor of severity of coronary artery disease in 2976 patients

Modi, R., Patted, S. V., Halkati, P. C., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.093 · Cited by 35

Designs of RADIANCE 1 and 2:carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis

Kastelein, J. J. P., van Leuven, S. I., Evans, G. W., Riley, W. A., Revkin, J. H., Shear, C. L., Bots, M. L., & on behalf of the RADiANCE 1 and 2 study investigators (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x182121 · Cited by 34

Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention

Ascaso, J. F., ndez-Cruz, A. F., Santos, P. G. L., Hernández‐Mijares, A., Mangas, A., n, J. M., Pallardo, L. F., Pedro‐Botet, J., Pérez‐Jiménez, F., a, G. P., et al. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00003 · Cited by 36

The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)

van Hateren, K. J. J., Landman, G. W. D., Kleefstra, N., Logtenberg, S. J. J., Groenier, K. H., Kamper, A. M., Houweling, S. T., & Bilo, H. J. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008464 · Cited by 34

Management of dyslipidaemia

Thompson, G. R. (2004) · Heart · doi:10.1136/hrt.2003.021287 · Cited by 35

Influence of ApoE and FABP2 polymorphisms and environmental factors in the susceptibility to gallstone disease

Martínez‐López, E., Curiel-López, F., Hernández-Nazará, A., et al. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31173-1 · Cited by 34

Cholesteryl ester transfer protein inhibitors: challenges and perspectives

Filippatos, T. D., Klouras, E., Barkas, F., & Elisaf, M. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1189327 · Cited by 34

Original research Genetic variability and the risk of myocardial infarction in Poles under 45 years of age

Sakowicz, A., Fendler, W. M., Lelonek, M., et al. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.13887 · Cited by 34

Poor or fair self-rated health is associated with depressive symptoms and impaired perceived physical health: A cross-sectional study in a primary care population at risk for type 2 diabetes and cardiovascular disease

Rantanen, A., Korkeila, J., Kautiainen, H., & Korhonen, P. (2019) · European Journal of General Practice · doi:10.1080/13814788.2019.1635114 · Cited by 22

Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era

Allahham, M., Lerman, A., Atar, D., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07224-9 · Cited by 34

Changes in diet, exercise and stress behaviours using the stages of change model in cardiac rehabilitation patients

McKee, G., Bannon, J., Kerins, M., & Fitzgerald, G. (2006) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2006.10.002 · Cited by 34

Relationship of fibrinogen with arterial stiffness and wave reflections

Vlachopoulos, C. V., Pietri, P. G., Aznaouridis, K. A., Vyssoulis, G. P., Vasiliadou, C., Bratsas, A., Tousoulis, D., Xaplanteris, P., Stefanadi, E., & Stefanadis, C. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282dc25da · Cited by 34

A randomized, controlled trial for risk factor reduction in patients with symptomatic vascular disease: the multidisciplinary Vascular Prevention by Nurses Study (VENUS)

Goessens, B. M. B., Visseren, F. L. J., Sol, B. G. M., Ginkel, J. M. D. M., & van der Graaf, Y. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000216549.92184.40 · Cited by 34

A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors

Hansen, T., Ahlström, H. K., Wikström, J., et al. (2008) · European Radiology · doi:10.1007/s00330-008-0864-6 · Cited by 34

Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia

Mengual, L., Roura, P., Serra, M., Montasell, M., Prieto, G., & Bonet, S. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-14 · Cited by 33

Intrusion and Confusion—The Impact of Medication and Health Professionals after Acute Myocardial Infarction

Attebring, M. F., Herlitz, J. D., & Ekman, I. (2005) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2005.02.001 · Cited by 38

Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: update on recent trials and metaanalyses

Briel, M., Nordmann, A. J., & Bucher, H. C. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.mol.0000191502.39831.ba · Cited by 34

Implications of emerging risk factors for therapeutic intervention

Assmann, G., Cullen, P., Fruchart, J., Greten, H., Naruszewicz, M., OLSSON, A. G., Paoletti, R., Riesen, W., Stoll, M., Tikkanen, M. J., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.011 · Cited by 33

Adaptación española de la Guía Europea de Prevención Cardiovascular

Brotons, C., Royo‐Bordonada, M. Á., Álvarez-Sala, L., Armario, P., Artigao, R., Conthe, P., de Álvaro, F., de Santiago, A., Gil, A., Lobos, J. M., et al. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)78927-1 · Cited by 45

High performance liquid chromatography mass spectrometric method for the simultaneous quantification of pravastatin and aspirin in human plasma: Pharmacokinetic application

Polagani, S. R., Pilli, N. R., & Gandu, V. (2012) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2012.01.001 · Cited by 32

The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases

García‐Rodríguez, L. A., González‐Pérez, A., Stang, M. R., Wallander, M.-A. A., & Johansson, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1602 · Cited by 33

Association of Metabolic and Genetic Factors With Cholesterol Esterification Rate in HDL Plasma and Atherogenic Index of Plasma in a 40 Years Old Slovak Population

Rašlová, K., Dobiášová, M., Hubacek, J. A., Benčová, D., Siváková, D., Daňková, Z., Franeková, J., Jabor, A., Gašparovič, J., & Vohnout, B. (2011) · Physiological Research · doi:10.33549/physiolres.932069 · Cited by 33

Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies

Masson, S., Latini, R., Tacconi, M. T., & Bernasconi, R. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000289269.98105.65 · Cited by 32

Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients

Silva, M. G., Borba, E. F., de Mello, S. B. V., & Shinjo, S. K. (2016) · Clinics · doi:10.6061/clinics/2016(12)06 · Cited by 34

An affordable, rapid determination of total lipid profile using paper-based microfluidic device

Parween, S., Subudhi, P. D., & Asthana, A. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.01.064 · Cited by 33

The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study

Jozwiak, J. J., Studziński, K., Tomasik, T., Windak, A., Mastej, M., Catapano, A. L., Ray, K. K., Mikhailidis, D. P., Toth, P. P., Howard, G., et al. (2020) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2021.01.004 · Cited by 33

The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study

Mueller, A. M., Liakoni, E., Schneider, C., Burkard, T., Jick, S. S., Krähenbühl, S., Meier, C. R., & Spoendlin, J. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06651-6 · Cited by 33

The Mosque Campaign: a cardiovascular prevention program for female Turkish immigrants

Bader, A., Musshauser, D., Sahin, F., Bezirkan, H., & Hochleitner, M. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0587-0 · Cited by 33

Using noncontrast cardiac CT and coronary artery calcification measurements for cardiovascular risk assessment and management in asymptomatic adults

Rumberger, J. A. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7457 · Cited by 33

Implementation of an online tailored physical activity intervention for adults in Belgium

Spittaels, H., & Bourdeaudhuij, I. D. (2006) · Health Promotion International · doi:10.1093/heapro/dal030 · Cited by 32

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study

Danese, M. D., Gleeson, M. L., Kutikova, L., Griffiths, R. I., Khunti, K. K., Seshasai, S. R. K., & Ray, K. K. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013851 · Cited by 31

Improving lipid management - to titrate, combine or switch

Schuster, H. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00188.x · Cited by 33

Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: The Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study

Martineau, P., Gaw, A. J., de Teresa, E., Farsang, C., Gensini, G. F., Leiter, L. A., & Langer, A. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.019 · Cited by 33

Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2

Csenteri, O. K., Jancsó, Z., Szöllösi, G. J., Andreka, P. G., & Vajer, P. (2022) · Open Heart · doi:10.1136/openhrt-2022-002087 · Cited by 32

¿La diabetes mellitus es un equivalente de riesgo coronario? Resultados de un metaanálisis de estudios prospectivos

González-Clemente, J. M., Palma, S., Arroyo, J., Vilardell, C., Caixàs, A., Giménez‐Palop, O., & Delgado‐Rodríguez, M. (2007) · Revista Española de Cardiología · doi:10.1157/13111789 · Cited by 32

The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes

Baxter, M. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0052-9 · Cited by 31

Chapter III: Management of Cardiovascular Risk Factors and Medical Therapy

Diehm, N., Schmidli, J., Setacci, C., Ricco, J., de DONATO, G., Becker, F., Robert‐Ebadi, H., Cao, P., Eckstein, H., Rango, P. D., et al. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(11)60011-7 · Cited by 32

Contemporary Management and Attainment of Cholesterol Targets for Patients with Dyslipidemia in China

Gao, F., Zhou, Y. J., Hu, D. Y., Zhao, Y. X., Liu, Y. Y., Wang, Z. J., Yang, S. W., & Liu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0047681 · Cited by 31

Is There Evidence for Mandating Electrocardiogram as Part of the Pre-Participation Examination?

Börjesson, M., & Dellborg, M. (2010) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e318204a7b4 · Cited by 32

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

Palanca, A., Castelblanco, E., Betriu, À., Perpiñán, H., Soldevila, B., Valdivielso, J. M., Bermúdez-López, M., Puig-Jové, C., Puig‐Domingo, M., Groop, P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0897-y · Cited by 32

Effects of Fish Oil Supplementation on Oxidative Stress Biomarkers and Liver Damage in Hypercholesterolemic Rats

Rocha, J. É. L., Furtado, M. M., Neto, R. S. M., et al. (2022) · Nutrients · doi:10.3390/nu14030426 · Cited by 32

A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease

Lamotte, M., Annemans, L., Evers, T., & Kubin, M. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624020-00005 · Cited by 31

The importance of total cardiovascular risk assessment in clinical practice

Graham, I. M. (2006) · European Journal of General Practice · doi:10.1080/13814780600976282 · Cited by 32

The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study

Brouwer, B. G., Visseren, F. L. J., & van der Graaf, Y. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.031 · Cited by 30

Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease

Sarecka‐Hujar, B., Żak, I., & Krauze, J. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0022-0 · Cited by 32

Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients

Birjmohun, R. S., Kastelein, J. J. P., Poldermans, D., Stroes, E. S. G., Hostalek, U., & Assmann, G. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x199682 · Cited by 32

New approaches in the intensive management of cardiovascular risk in the metabolic syndrome

Rosenson, R. S. (2005) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2004.10.001 · Cited by 31

Quality of Life Predictors in Chronic Stable Post-Stroke Patients and Prognostic Value of SF-36 Score as a Mortality Surrogate

Kielbergerová, L., Mayer, O., Vaněk, J., Bruthans, J., Wohlfahrt, P., & Cífková, R. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0418-6 · Cited by 31

Hypocholesterolemic properties of grapefruit (Citrus paradisii) and shaddock (Citrus maxima) juices and inhibition of angiotensin-1-converting enzyme activity

Oboh, G., Bello, F. O., & Ademosun, A. O. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.06.005 · Cited by 31

Effects of Prescription Omega-3-Acid Ethyl Esters on Fasting Lipid Profile in Subjects With Primary Hypercholesterolemia

Maki, K. C., Lawless, A. L., Kelley, K., Dicklin, M. R., Kaden, V. N., Schild, A. L., Rains, T. M., & Marshall, J. W. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318210fca5 · Cited by 31

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

Arafah, M., Al-Hinai, A. T., Almahmeed, W. A., Al‐Rasadi, K., Tamimi, O. A., Herz, S. A., Anazi, F. A., Nemer, K. A., Metwally, O., Al-Khadra, A. H., et al. (2013) · Angiology · doi:10.1177/0003319713512414 · Cited by 31

Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No

Kendrick, M. E. (2007) · BMJ · doi:10.1136/bmj.39202.397488.ad · Cited by 31

Medical guidelines presentation and comparing with Electronic Health Record

Veselý, A., Zvárová, J., Peleška, J., et al. (2005) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2005.07.016 · Cited by 31

Fractura osteoporótica: valoración del riesgo en la práctica clínica

Díaz, M. V., Franco, A., Zaragozá, C. I., & Aguado, P. (2007) · Medicina Clínica · doi:10.1157/13110466 · Cited by 31

Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal

Tamang, H. K. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7588.4000 · Cited by 31

Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys

Cournot, M., Cambou, J., Quentzel, S., & Danchin, N. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.039 · Cited by 31

Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery

Feringa, H. H. H., Schouten, O., Karagiannis, S. E., Brugts, J. J., Elhendy, A. A., Boersma, E. H., Vidaković, R., van Sambeek, M. R. H. M., Noordzij, P. G., Bax, J. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.046 · Cited by 31

Disease Knowledge and Adherence to Treatment in Patients With Familial Hypercholesterolemia

Hollman, G., OLSSON, A. G., & Ek, A. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200603000-00005 · Cited by 30

Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy

van Schaik, T. M., Jorstad, H. T., Twickler, T. B., et al. (2017) · Netherlands Heart Journal · doi:10.1007/s12471-017-0963-6 · Cited by 30

Patient Characteristics and General Practitioners’ Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries

van der Ploeg, M. A., Streit, S., Achterberg, W. P., Beers, E., Bohnen, A. M., Burman, R. A., Collins, C., Franco, F. G. D. M., Gerasimovska-Kitanovska, B., Gintere, S., et al. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4795-x · Cited by 30

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease

Mayer, O., Seidlerová, J., Černá, V., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.05.008 · Cited by 30

An artificial class modelling approach to identify the most largely diffused cultivars of sweet cherry (Prunus avium L.) in Italy

Ceccarelli, D., Antonucci, F., Costa, C., et al. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127515 · Cited by 30

Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease

Jordi, S. B. U., Botte, F., Lang, B. M., Greuter, T., Krupka, N., Auschra, B., Schreiner, P., Sulz, M. C., Biedermann, L., von Känel, R., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16365 · Cited by 30

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets

McCormack, T., Harvey, P., Gaunt, R., et al. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02429.x · Cited by 30

Síndrome metabólica, resistência à ação da insulina e doença cardiovascular no diabete melito tipo 1

Rodrigues, T. D. C., Canani, L. H. S., & Gross, J. L. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010000100020 · Cited by 30

Committee and Task Force Reports: Youth and Families Task Force Report

James, S., Jordan, K., Lasser, J. S., et al. (1997) · PsycEXTRA Dataset · doi:10.1037/e413432005-005

Ethnic Minority Elderly: A Task Force Report of the American Psychiatric Association

Busse, E. W. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199524310-00013 · Cited by 1

Committee and Task Force Reports: Task Force on Aging

Carlson, H. M., & David, S. (2004) · PsycEXTRA Dataset · doi:10.1037/e373992004-024

Committee and Task Force News: Task Force on Students-at-Risk

Kaslow, F. W., & Olson, D. L. (1991) · PsycEXTRA Dataset · doi:10.1037/e410102005-024 · Cited by 1

Update From the American Psychiatry Association's Task Force on Electroconvulsive Therapy

McDonald, W. M., Prudic, J., McCall, W. V., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.078 · Cited by 3